Valneva SE (VALN) Accumulated Expenses (2020 - 2025)

Valneva SE's (VALN) quarterly Accumulated Expenses came in at $14.7 million in Q4 2025, up 5.07% year-on-year from $14.0 million in Q4 2024, and up 5.07% quarter-over-quarter from $14.0 million in Q4 2024.

Valneva SE (VALN) Accumulated Expenses (2020 - 2025) Analysis & Trends

Valneva SE has disclosed Accumulated Expenses across 6 years of filings, most recently posting $14.7 million for Q4 2025.

  • Accumulated Expenses for Q4 2025 came in at $14.7 million, up 5.07% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.7 million (up 5.07% YoY), and the FY2025 annual result was $14.7 million, up 5.07% from the prior year.
  • Accumulated Expenses came in at $14.7 million for Q4 2025 at Valneva SE, up from $14.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $14.7 million in Q4 2025 to a low of $10.9 million in Q2 2024.
  • The 5-year median for Accumulated Expenses is $11.6 million (2021), against an average of $12.3 million.
  • Across the five-year window, Accumulated Expenses fell 4.84% in 2022 and grew 20.37% in 2024, its largest moves.
  • Valneva SE's Accumulated Expenses stood at $11.6 million in 2021, then retreated by 4.84% to $11.0 million in 2022, then gained by 5.82% to $11.6 million in 2023, then gained by 20.37% to $14.0 million in 2024, then climbed by 5.07% to $14.7 million in 2025.
  • The last three Accumulated Expenses figures came in at $14.7 million (Q4 2025), $14.0 million (Q4 2024), and $10.9 million (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn -
7 Psyence Biomedical 241.78 Bn 241.78 Bn -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn
9 Abivax 94.26 Bn 94.26 Bn -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 14.72 Mn
Dec 31, 2024 14.01 Mn
Jun 30, 2024 10.93 Mn
Dec 31, 2023 11.64 Mn
Dec 31, 2022 11.00 Mn
Dec 31, 2021 11.56 Mn
Dec 31, 2020 9.90 Mn